quinazolines has been researched along with Acid beta-Glucosidase Deficiency in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burbulla, LF; Jeon, S; Jiang, W; Krainc, D; Oevel, K; Silverman, RB; Ysselstein, D; Zheng, J | 1 |
| Chen, L; Krainc, D; Schwake, M; Silverman, RB; Zheng, J | 1 |
| Aungst, RA; Austin, CP; Goldin, E; Lea, WA; Leister, W; Marugan, JJ; Motabar, O; Sidransky, E; Simeonov, A; Southall, N; Stubblefield, BK; Westbroek, W; Zheng, W | 1 |
3 other study(ies) available for quinazolines and Acid beta-Glucosidase Deficiency
| Article | Year |
|---|---|
Conversion of Quinazoline Modulators from Inhibitors to Activators of β-Glucocerebrosidase.
Topics: Dopaminergic Neurons; Enzyme Activators; Enzyme Inhibitors; Gaucher Disease; Glucosylceramidase; Humans; Methylation; Parkinson Disease; Quinazolines; Structure-Activity Relationship | 2019 |
Design and Synthesis of Potent Quinazolines as Selective β-Glucocerebrosidase Modulators.
Topics: Cell Line; Drug Design; Enzyme Stability; Gaucher Disease; Glucosylceramidase; Humans; Parkinson Disease; Quinazolines | 2016 |
Evaluation of quinazoline analogues as glucocerebrosidase inhibitors with chaperone activity.
Topics: Cell Line; Fibroblasts; Gaucher Disease; Glucosylceramidase; Humans; Hymecromone; Immunohistochemistry; Lysosomes; Magnetic Resonance Spectroscopy; Microscopy, Confocal; Molecular Chaperones; Quinazolines; Spectrometry, Mass, Electrospray Ionization; Spleen; Structure-Activity Relationship | 2011 |